Emerging CAR T-Cell Therapies – OncLive
OncLive |
Emerging CAR T-Cell Therapies
OncLive Anas Younes, MD: So, when we talk about CAR T cells, it's a platform. There are 3 different company-sponsored products. There are similarities and some differences. The major similarity between Kite, Novartis, and Juno is that they all target CD19 … |
